The strong allogeneic response to donor MHC molecules in transplantation and the weak response to tumor antigens represent ... responses to tumor peptides. Some novel approaches have been ...

for example, checkpoint inhibitors tend to be ineffective. CAR-T cells, engineered to recognize tumor-specific antigens, although successful in some blood cancers and lymphomas, have not been ...

PSMA is a dimeric type II integral membrane glycoprotein, highly expressed on prostate cancer cells. It has been shown to be a predictor for prostate cancer progression and for prognosis of prostate ...